Cenergy Holdings SA (CENER)
Euronext Brussels · Belgium · prices in EUR · close of 22 Oct 2026
Key indicators
| Last close | EUR 21.66 |
|---|---|
| 52-week range | 13.40 – 28.20 |
| Return, 1 month / 3 months | −6.5% / +0.5% |
| Return, 1 year / 3 years | +62.6% / +296.0% |
| Trend | Below its 200-day average |
| RSI (14) | 41 |
| Volatility (1 year) | 48.5% |
| Worst drawdown (1 year) | -27.2% |
| Average daily value traded | 0.30M EUR |
| Dividend yield | 1.2% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Cenergy Holdings is a holding company whose subsidiaries make cables and steel pipes. Hellenic Cables produces power and telecommunications cables for utilities, industry and infrastructure projects, while Corinth Pipeworks manufactures large steel pipes used in oil and gas pipelines, including offshore and onshore line pipe. The company serves energy, construction and utility customers in Europe and beyond, and it is based in Belgium with its industrial operations centred in Greece.
On this site Cenergy Holdings SA appears as a stock on the Euronext Brussels (Belgium), code CENER, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 4 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Cenergy Holdings SA (CENER) trades on the Euronext Brussels in Belgium. It last closed at EUR 21.66 on 22 October 2026.
Its price-based Market X-Ray is 53 out of 100 (a fair price profile), ranking 56 of 111 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 62.6% and over the last three months it rose 0.5%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on Euronext Brussels
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -0.3% | ||
| From 52-week high | -22.1% | ||
| Momentum | 82 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 0.5% | ||
| 6-month return | 5.8% | ||
| 12-month return, skipping the last month | 73.8% | ||
| Stability (higher is calmer) | 31 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 48.5% | ||
| Worst drawdown, 1 year (smaller is calmer) | -27.2% | ||
| Liquidity | 57 · Fair | Moderate trading activity. | |
| Average daily value traded | 0.30M EUR | ||
| Zero-volume days | 0.0% | ||
| Income | 13 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.2% | ||
| Years with dividends | 4 |
Strengths
- Momentum: Rising faster than most stocks on this exchange.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | −0.6% |
|---|---|
| 1 month | −6.5% |
| 3 months | +0.5% |
| 6 months | +5.8% |
| 1 year | +62.6% |
| 3 years | +296.0% |
| 5 years | +751.1% |
Signals
| 50-day / 200-day average | 22.81 / 21.72 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 22 Jun 2026 | EUR 0.2600 |
| 24 Jun 2025 | EUR 0.0980 |
| 25 Jun 2024 | EUR 0.0560 |
| 19 Jun 2023 | EUR 0.0500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on Euronext Brussels; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.